Franklin Biolabs is a trusted resource for academic and industry investigators utilizing virus-based vectors for gene transfer in preclinical studies and other research applications critical to the development of genetic medicines products. We have generated >27,000 research batches to date in support of clients across >30 countries. Our experts have supported >50 clinical-stage programs based on our capsid technology. The team has also performed >50 GMP manufacturing runs, achieving a 100% successful IND approval rate since 2019. Vector manufacturing at Franklin Biolabs is supported by an established platform of analytical assays for hundreds of products.